DNA Aptamers Selected against the HIV-1 RNase H Display in Vitro Antiviral Activity

Citations Over TimeTop 12% of 2001 papers

Abstract

The DNA polymerase of the human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) is a target widely used to inhibit HIV-1 replication. In contrast, very few inhibitors of the RNase H activity associated with RT have been described, despite the crucial role played by this activity in viral proliferation. DNA ligands with a high affinity for the RNase H domain of HIV-1 RT were isolated by systematic evolution of ligands by an exponential enrichment strategy (SELEX), using recombinant RTs with or without the RNase H domain. The selected oligonucleotides (ODNs) were able to inhibit in vitro the HIV-1 RNase H activity, while no effect was observed on cellular RNase H. We focused our interest on two G-rich inhibitory oligonucleotides. Model studies of the secondary structure of these ODNs strongly suggested that they were able to form G-quartets. In addition to the inhibition of HIV-1 RNase H observed in a cell free system, these ODNs were able to strongly diminish the infectivity of HIV-1 in human infected cells. Oligonucleotides described here may serve as leading compounds for the development of specific inhibitors of this key retroviral enzyme activity.

Related Papers

• → Interaction with Single-stranded DNA-binding Protein Stimulates Escherichia coli Ribonuclease HI Enzymatic Activity(2015)73 cited
• → Crystal structure of metagenome-derived LC11-RNase H1 in complex with RNA/DNA hybrid(2013)7 cited
• → Antisense Inhibition of Escherichia coli RNase P RNA: Mechanistic Aspects(2003)15 cited
• → RraAa Protein Inhibitor of RNase E Activity that Globally Modulates RNA Abundance in E. coli(2003)11 cited
• → Identification of the gene encoding a type 1 RNase H with an N‐terminal double‐stranded RNA binding domain from a psychrotrophic bacterium(2007)9 cited